Skip to main content

Education First

Site section 6 of 12

Blood biomarkers are signals, systems, and context.

A lab-literacy course on panels, specimens, assays, reference frameworks, trends, confounders, bottom lines, and the relationships that connect blood work to broader biological systems.

Learning progress

Progress is private to this browser.

Primary learning surface

Formula workbench

Formulas are educational models with assumptions. Choose a formula, set the synthetic inputs, and watch which input moves which result and where the equation stops applying.

Modeled
Formula
LDL-C equation
190mg/dL
52mg/dL
150mg/dL

Non-HDL-C = 190 − 52mg/dL

LDL-C = 190 − 52 − 150/5mg/dL

TCHDL-CLDL-C

Non-HDL-C

138mg/dL

LDL-C, Friedewald

108mg/dL

Remnant cholesterol

30mg/dL

non-HDL-C minus LDL-C

Lipid partition with synthetic inputs. Non-HDL cholesterol 138 milligrams per deciliter. LDL cholesterol by the Friedewald equation 108 milligrams per deciliter. Remnant cholesterol 30 milligrams per deciliter.

Method and sources

Non-HDL-C = TC − HDL-C; LDL-C = TC − HDL-C − TG/5

What it shows: Splits a synthetic total cholesterol into HDL-C, LDL-C and remnant cholesterol, with LDL-C estimated by the equation you choose.

How to read it: Move a control and read the substituted equation and the geometry in the field, and the result in the tiles. A result outside the equation’s stated use prints as not computed, with the reason.

Assumptions: All values in mg/dL. Friedewald is not applied above TG 400 mg/dL and Sampson above TG 800 mg/dL. A set that gives LDL-C at or below zero, or no remnant, is not computed. The Martin-Hopkins equation needs its published factor table and is not modeled here.

Sources:
  • Friedewald WT, Levy RI, Fredrickson DS. Clin Chem 1972;18:499-502 LDL-C = TC - HDL-C - TG/5 in mg/dL, stated for TG to 400 mg/dL.
  • Sampson M et al. JAMA Cardiol 2020;5:540-548 NIH equation 2, stated for TG to 800 mg/dL.
These controls use synthetic values to show arithmetic only. They are not personal targets, personal ranges, or individualized interpretation.

Check yourself

Stop the red-number reflex.

A learner sees one flagged marker and wants an instant health conclusion. The course has to force specimen, method, reference framework, trend, and panel context back into the decision.

Choose the next move

Pick an answer to see why.

Course spine

The course teaches measurement before meaning.

Most learners see panels, not isolated analytes. This course starts with context, specimen, method, and reference framework, then moves into panel clusters and systems relationships.

  1. 01 / Signals

    Blood biomarkers as measured signals, not verdicts.

  2. 02 / Measurement

    How specimen type, tube, timing, handling, and assay method create the number.

  3. 03 / Frameworks

    How to separate reference intervals, decision limits, critical values, risk categories, and assay-specific percentiles.

  4. 04 / Panels

    How grouped panels organize biology before any one marker is discussed.

  5. 05 / Systems

    How marker clusters connect inflammation, insulin resistance, lipid transport, ketogenesis, kidney buffering, liver processing, thyroid tempo, oxygen transport, and coagulation.

  6. 06 / Bottom line

    How to write a safe bottom line and convert uncertainty into questions for a qualified healthcare professional.

Reading workflow

A report is read in a fixed order.

The workflow prevents the common mistake of treating the red number as the answer. Context, panel identity, cluster behavior, reference framework, trend, and caveat come first.

  1. 01 / Confirm report context

    Check date, fasting state, time, lab, specimen, units, medications, illness, exercise, hydration, pregnancy or menstrual context, and supplements.

  2. 02 / Identify the panel

    Name the panel before naming the outlier: CBC, BMP, CMP, lipid, glycemic, kidney, liver, inflammatory, thyroid, coagulation, hormone, or specialized.

  3. 03 / Read clusters

    Mark which markers belong together, then decide whether the pattern is cellular, chemical, filtration, metabolic, inflammatory, endocrine, or hemostatic.

  4. 04 / Separate frameworks

    Do not mix reference intervals, decision limits, critical values, risk categories, or assay-specific percentiles.

  5. 05 / Compare like with like

    Prefer prior values from the same lab and method when available, while distinguishing analytical variation from biological variation.

  6. 06 / Ask what can distort it

    Check sample quality, timing, method, medications, acute illness, exercise, diet, hydration, kidney function, liver function, and RBC turnover.

  7. 07 / Write the bottom line

    State what the panel can organize, what it cannot prove, what changes interpretation, and which question belongs with a qualified professional.

Lab foundations

Specimen and assay context are part of the result.

A biomarker value is not just biology. It is specimen, tube, collection, storage, transport, method, calibration, interference, and reporting framework.

Pre-analytic distortion map

Choose a collection or handling factor to read what it can distort and the question it raises.

Factor

Fasting status

What it can distort
Glucose, triglycerides, insulin, and some metabolites.
Families affected
glycemic, lipid, ketone
Why it matters
Meal timing changes several signals before any long-term pattern is inferred.
Safe question
Was the sample fasting, and for how long?

Analytical interference model

Choose an interference to read what it can distort inside the assay and the question it raises.

Factor

Hemolysis

What it can distort
Potassium, AST, bilirubin context, enzymes, and optical assays.
Families affected
chemistry, liver
Why it matters
Cell rupture creates analytical and biological ambiguity.
Safe question
Did the report flag hemolysis?

Reference frameworks

Reference interval is not the same thing as decision threshold.

Every marker declares exactly one framework so the page does not collapse population distributions, clinical decision limits, critical communication thresholds, and assay-specific percentiles into one generic range.

Reference interval
Comparison to a population and method distribution.
Decision limit
Guideline or clinical decision threshold, not a lab population range.
Critical value
Urgent communication threshold set by laboratory policy.
Risk category
Population risk category, not an individual diagnosis.
Assay-specific percentile
Threshold depends on the assay and clinical context.
Not applicable
A concept or qualitative teaching item with no numeric framework.

Formula reference

Non-HDL-C
total cholesterol minus HDL-CUse as lipid transport literacy only.
Anion gap
sodium minus chloride minus bicarbonateDo not interpret without clinical context.
BUN/creatinine ratio
BUN divided by creatinineRatio alone does not prove cause.
Transferrin saturation
serum iron divided by TIBC, multiplied by 100Use with CBC and ferritin context.
HOMA-IR concept
fasting insulin times fasting glucose, divided by a model constantDo not use as a public diagnosis tool.

Panel atlas

Panels are the reader’s entry point.

Each panel explains what it groups, which markers move together, common traps, missing context, cross-panel relationships, and the bottom-line framework.

Panel navigator

Choose a panel to read what it groups, what to read first, the common traps, and the bottom line it can and cannot support.

Panel
CBCComplete blood count

CBC with differential

Which cell family is changing: red cells, white cells, platelets, or a mixed pattern?

Read first
  • Hemoglobin
  • WBC
  • Platelets
Read together
  • hemoglobin with hematocrit and RBC indices
  • WBC with differential
  • platelets with inflammation or clotting context
Common traps
  • Recent infection or hard exercise can move WBC patterns.
  • Dehydration can concentrate cell counts.
  • Bleeding history
  • nutrient status
Cross-panel links
  • Iron and hematinics panel
  • Inflammation panel
  • Coagulation panel
What this can organize
Cell counts can organize oxygen-carrying, immune-cell, and platelet-count patterns.
What this cannot prove
A panel pattern cannot prove a diagnosis, prognosis, treatment need, or personal status by itself.
What changes interpretation
Recent illness, exercise, hydration, sample clotting
What to ask next
Which result should be repeated, confirmed, or interpreted with history by a qualified healthcare professional?

Included markers

  • WBC: Count of leukocytes in whole blood.
  • Neutrophils: Absolute or relative neutrophil count.
  • Lymphocytes: Absolute or relative lymphocyte count.
  • RBC: Number of red cells in whole blood.
  • Hemoglobin: Hemoglobin concentration in blood.
  • Hematocrit: Fraction of blood volume occupied by red cells.
  • MCV: Average red-cell volume.
  • RDW: Variation in red-cell size.
  • Platelets: Number of platelets in whole blood.

Every marker keeps its measurement machinery.

Showing markers from Glycemic panel. Each states what is measured, specimen, units, reference framework, and companion markers. No marker here can prove a diagnosis, prognosis, treatment need, or personal health status by itself.

Glucose

Decision limit

direct
Measured
Glucose concentration in blood.
Specimen
serum or plasma
Units
mg/dL, mmol/L
Companion markers
A1c, Insulin, Connecting-segment (C) chain, Beta-hydroxybutyrate

A1c

Decision limit

direct
Measured
Glycated hemoglobin proportion.
Specimen
whole blood
Units
%
Companion markers
Glucose, Hemoglobin, MCV, Creatinine

Insulin

Assay-specific percentile

direct
Measured
Insulin concentration in blood.
Specimen
serum or plasma
Units
µIU/mL, pmol/L
Companion markers
Glucose, Connecting-segment (C) chain, Triglycerides

Connecting-segment (C) chain

Assay-specific percentile

direct
Measured
The connecting segment released with endogenous insulin production.
Specimen
serum or plasma
Units
ng/mL, nmol/L, pmol/L
Companion markers
Glucose, Insulin, A1c

Systems map

Markers relate across organs and time windows.

The same value can be re-framed by inflammation, kidney filtration, liver processing, thyroid feedback, RBC turnover, and specimen context.

Pre-analytic factorsall markers

Specimen context precedes marker meaning.

Inflammation panelFerritin

Ferritin can represent iron stores and acute-phase context.

Glycemic panelLipid and lipoprotein panel

Energy handling can move triglyceride and HDL-C patterns.

Kidney panelA1c

Kidney and red-cell context can change A1c interpretation.

Thyroid panelLipid and lipoprotein panel

Thyroid axis context can change lipid patterns.

Liver and biliary panelInflammation panel

The liver produces several acute-phase proteins.

Ketone and acid-base panelGlycemic panel

Ketones require glucose and acid-base context.

Coagulation panelLiver and biliary panel

PT/INR can reflect clotting and liver synthetic context.

High-caution bay.

These markers require context-first teaching. The course explains why overreading is risky and routes urgency language back to the lab, clinician, or emergency instructions when symptoms or critical flags exist.

High-sensitivity troponin

Read against assay-specific cutoffs and timed repeat draws; the change between draws carries meaning that one value cannot.

D-dimer

Rises with many processes, including recent surgery, inflammation, pregnancy, and age, so it is read within a defined pretest context, never alone.

Tumor markers

Not specific to one tissue or condition and can rise in benign states; assays are not interchangeable, so a trend is read on one method.

Broad hormone panels

Pulsatile release, time of day, cycle phase, and binding proteins move values, and a wide panel multiplies chance flags.

A1c caveats

Reflects glycation over red-cell lifespan, so anemia, altered turnover, hemoglobin variants, and kidney context can shift it away from average glucose.

Ferritin caveats

An acute-phase protein as well as an iron-storage signal, so inflammation, liver context, and recent illness can raise it independently of stores.

eGFR and UACR

eGFR is an equation estimate from creatinine or cystatin C, and UACR varies day to day, so persistence needs repeat measurements.

CRP and ESR

Nonspecific inflammation signals that move with infection, injury, and many other contexts; neither names a cause.

Capstone

The learner builds bottom lines, not diagnoses.

Each capstone asks for panel identity, clusters, missing context, what the pattern can organize, what it cannot prove, and the safe question to take to a qualified professional.

One red number

Basic metabolic panel

A synthetic chemistry panel has one isolated outlier and no prior trend.

  • Identify the panel.
  • List pre-analytic checks.
  • Write what the value can organize and cannot prove.

No personal interpretation or self-directed action.

Energy pattern

Glycemic panelLipid and lipoprotein panelLiver and biliary panelInflammation panel

Synthetic glucose, A1c, triglyceride, HDL-C, ALT, and CRP pattern.

  • Group the markers.
  • Name the missing context.
  • Write a qualified-professional question.

No universal screening or protocol advice.

Normal creatinine, abnormal UACR

Kidney panel

Synthetic kidney example separates filtration estimate from albumin leak.

  • Compare eGFR and UACR.
  • List repeat-context variables.
  • Ask a safe next question.

No kidney-disease diagnosis from the course.

Fatigue lab literacy

CBC with differentialIron and hematinics panelInflammation panel

Synthetic CBC indices with ferritin, B12, folate, and CRP context.

  • Read cell indices first.
  • Pair storage and inflammation markers.
  • Avoid supplement instructions.

No self-supplement direction.

False alarm context

CBC with differentialInflammation panelLiver and biliary panel

Synthetic recent-illness or hard-workout example with WBC, CRP, AST, and ALT movement.

  • Identify transient contexts.
  • List what would support persistence.
  • Write bottom-line fields.

No reassurance or alarm based on the course alone.

Heart risk conversation

Lipid and lipoprotein panelKidney panelGlycemic panel

Synthetic lipid markers with missing age, blood-pressure, smoking, diabetes, family-history, and kidney context.

  • Separate lipid transport from risk calculation.
  • Name missing risk variables.
  • Ask what tool a clinician would use.

No personal risk calculator.

Source record, 20 sources

Every claim on this page points back to one of these sources.

MedlinePlus complete blood count

NLM MedlinePlus / accessed 2026-07-02

CBC plain-language panel composition.

MedlinePlus basic metabolic panel

NLM MedlinePlus / accessed 2026-07-02

BMP plain-language panel composition.

MedlinePlus comprehensive metabolic panel

NLM MedlinePlus / accessed 2026-07-02

CMP plain-language panel composition.

MedlinePlus lab-result interpretation

NLM MedlinePlus / accessed 2026-07-02

Reference range and provider-context literacy.

CDC clinical laboratory standardization

CDC / accessed 2026-07-02

Accuracy, precision, and standardization literacy.

ADA Standards of Care

American Diabetes Association / accessed 2026-07-02

Glycemic decision-limit source anchor.

AHA/ACC dyslipidemia guideline page

American Heart Association / accessed 2026-07-02

Lipid and lipoprotein risk-context source anchor.

KDIGO CKD guideline

KDIGO / accessed 2026-07-02

eGFR and albuminuria context.

American Thyroid Association thyroid function tests

American Thyroid Association / accessed 2026-07-02

Thyroid testing plain-language source anchor.

MedlinePlus C-reactive protein test

NLM MedlinePlus / accessed 2026-07-02

Inflammation marker literacy.

NCBI Bookshelf ketogenesis review

NCBI Bookshelf / accessed 2026-07-02

Ketogenesis physiology.

FDA RUO and IUO guidance

FDA / accessed 2026-07-02

Research-use boundary source.

21 CFR 809.10

eCFR / accessed 2026-07-02

In vitro diagnostic labeling boundary.

FTC health products compliance guidance

FTC / accessed 2026-07-02

Health-claim substantiation and public-copy boundary.

CLSI EP28 reference intervals

CLSI / accessed 2026-07-02

Reference-interval methodology source anchor.

CLSI EP07 interference testing

CLSI / accessed 2026-07-02

Analytical-interference methodology source anchor.

WHO blood collection guidance

WHO / accessed 2026-07-02

Specimen collection and phlebotomy context.

FDA biotin interference safety communication

FDA / accessed 2026-07-02

Biotin assay-interference source anchor.

CMS CLIA laboratory standards

CMS / accessed 2026-07-02

Clinical laboratory quality-system source anchor.

MedlinePlus cholesterol levels

NLM MedlinePlus / accessed 2026-07-02

Lipid-panel plain-language source anchor.

Course boundary

Lab literacy stays separate from personal care.

Back to course library

The next step is never a self-directed protocol. The next step is a clear question, prior reports, and qualified review when the pattern, persistence, symptoms, or lab flag calls for it.

Educational content only; not medical advice, diagnosis, treatment guidance, personal lab interpretation, self-triage, dosing guidance, or evidence that any catalog item changes a biological outcome. No uploads, no personal value entry, no personal lab-result reader, and no traffic-light scoring.

Editorial scope: chemical identity, experimental context, analytical methods, source quality and regulatory boundaries. Source references and stated limitations form part of the material; they should remain attached to quotations or summaries.

Lab and biomarker literacy path